Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation

Inclusion Criteria: * Provide a signed and dated informed consent to participate in the study including release of copyright of images * Man or woman aged 18 years or older * Be willing to abstain from any other facial plastic surgical or cosmetic procedures in close proximity to the treated area Exclusion Criteria: * Known/previous allergy or hypersensitivity to any injectable HA gel * History of bleeding disorder or treatment with anticoagulants, thrombolytics, or inhibitors of platelet aggregation, omega-3, or vitamin E within 2 weeks before treatment * Treatment with chemotherapy, immunosuppressive agents, immunomodulatory therapy, topical retinoids, systemic or topical corticosteroids within 3 months before treatment and systemic retinoids within 6 months before treatment * Previous tissue augmenting therapy or contouring with permanent filler, fat-injection or permanent implant placed in the area to be treated * The subject is, in the opinion of the investigator, unlikely to comply with the clinical investigational plan or is unsuitable for any other reason